Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Nov:116:105896.
doi: 10.1016/j.parkreldis.2023.105896. Epub 2023 Oct 10.

Electronic health record tools as a potential resource for improving care among hospitalized people with Parkinson's disease

Camila C Piccinin  1 , Jeryl Ritzi T Yu  2 , Anne Brooks  3 , Patricia Clark  4 , Shannon Shaffer  5 , Brent S Sokola  6 , Kim Lewin  7 , John-Paul Whitman  8 , Scott A Sperling  9 , Hubert H Fernandez  10 , Benjamin L Walter  11
Affiliations
Comment

Electronic health record tools as a potential resource for improving care among hospitalized people with Parkinson's disease

Camila C Piccinin et al. Parkinsonism Relat Disord. 2023 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: HHF has received research support from Biogen, Cerevel, Michael J. Fox Foundation, NIH/NINDS, Parkinson Study Group, Parkinson's Foundation, Roche but has no owner interest in any pharmaceutical company; has received honoraria from, Cleveland Clinic as a speaker in CME events; has received honoraria from Amneal, AbbVie, Cerevel, Neurocrine, Parkinson Study Group as a consultant. Elsevier as the Editor-In-Chief of Parkinsonism and Related Disorders Journal; has received royalty payments from Springer for serving as a book author/editor. BW serves as Section Head of Movement Disorders at the Cleveland Clinic. Over the years, he has received research grants from the NIH and Parkinson's Foundation. He has served as site investigator and/or co-investigator for clinical research studies sponsored by grants from Industry to Cleveland Clinic. Currently, he is the site PI for Neuroderm (Mitsubishi Tanabe Pharma), Discern (Great Lakes Neurotech/NIH R44), Tempo 2, and Tempo 3 studies (Cerevel Therapeutics) and a grant from the Parkinson's Foundation to improve the inpatient care of People with PD. He has served as a consultant or speaker for Medtronic, Boston Scientific, and Abbott for less than $5000 in the last year.

Comment on

LinkOut - more resources